[TREATMENT OF STATES OF HYPERALDOSTERONISM. THERAPEUTIC INDICATIONS OF SPIRONOLACTONE].
D006801:Humans; D006929:Hyperaldosteronism; D007659:Ketones; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D011427:Propiophenones; D011622:Pterins; D013148:Spironolactone; D014223:Triamterene
D007659:Ketones; D000451:Mineralocorticoid Receptor Antagonists; D011427:Propiophenones; D011622:Pterins; D013148:Spironolactone; D014223:Triamterene; D008797:Metyrapone
ALDOSTERONE ANTAGONISTS; HYPERALDOSTERONISM; KETONES; METYRAPONE; PROPIOPHENONES; PTERINS; SPIRONOLACTONE; TRIAMTERENE
TRAITEMENTS DES 'ETATS D'HYPERALDOST'ERONISME. INDICATIONS TH'ERAPEUTIQUES DES SPIROLACTONES.